We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
5 Broker-Appreciated Stocks to Keep an Eye on After Recent Analyst Upgrades
After performing impressively in September, volatility returned to grip the U.S. equity markets in October. The hotter-than-expected inflation reading for September has reignited recession fears. In September, the consumer price index rose 0.2% month over month, beating the consensus estimate of a 0.1% rise. These matters have not improved as geopolitical woes in the Middle East have intensified.
Given these headwinds, investors are well-advised to get help from brokers, who are experts in the field of investing, to design a winning portfolio of stocks. Broker-favorite stocks such as American Airlines, Air Canada, EmergentBioSolutions, Berry Corp. and Cracker Barrel Old Country Store should be monitored for this purpose.
We have designed a screen to shortlist stocks based on improving broker recommendations and upward revisions in earnings estimates over the past four weeks. Also, since the price/sales ratio is a strong complementary valuation metric in the presence of broker information, it has been included. The price/sales ratio takes care of the company’s top line, making the strategy a well-rounded one.
Here are five of the 10 stocks that made it through the screen:
American Airlines is based in Fort Worth, TX. The gradual increase in air travel demand (particularly leisure) aids AAL. However, high operating costs are hurting its bottom line.
Air Canada, Canada’s leading airline, is benefitting from the buoyant scenario concerning air travel demand. Driven by this tailwind, shares of this carrier have gained 16% in the past three months.
Over the past seven days, the Zacks Consensus Estimate for 2024 earnings has inched up 0.6%. ACDVF currently carries a Zacks Rank #3 (Hold).
Emergent BioSolutions, headquartered in Gaithersburg, MD, is a life sciences company. EBS currently has a Zacks Rank #2.
Emergent BioSolutions’ shares have lost 35.2% over the past three months, underperforming the industry’s 3% decline. Bottom-line estimates for EBS have narrowed to a loss of $1.30 per share from a loss of $1.98 for 2024 in the past 30 days. The company has a favorable VGM Score of B.
Berry is primarily involved in exploration and production activities, with its operations spreading across low-decline, long-lived oil and gas reserves in California and Utah. BRY can comfortably sail through a volatile energy business environment, banking on its strong liquidity and fortress balance sheet.
BRY shares have gained 6.2% over the past month. Over the past 60 days, the Zacks Consensus Estimate for current-year earnings has increased 4.9%. BRY currently carries a Zacks Rank #3.
Cracker Barrel is prioritizing menu innovation and strategic pricing to drive growth. The company is introducing the latest offerings, including shareable starters and specialty beverages, while optimizing pricing to enhance value. These initiatives aim to attract customers and support profitability.
CBRL has outpaced the Zacks Consensus Estimate for earnings in two of the last four quarters, missing the mark on two other occasions. The average beat is 3.1%. CBRL shares have gained 10.8% over the past three months. CBRL currently carries a Zacks Rank #3.
You can get the rest of the stocks on this list by signing up now for a 2-week free trial to the Research Wizard stock picking and backtesting software. You can also create your own strategies and test them first before making investments.
The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Shutterstock
Zacks.com featured highlights include American Airlines, Air Canada, EmergentBioSolutions, Berry and Cracker Barrel Old Country Store
For Immediate Release
Chicago, IL – October 28, 2024 – Stocks in this week’s article are American Airlines (AAL - Free Report) , Air Canada (ACDVF - Free Report) , EmergentBioSolutions (EBS - Free Report) , Berry Corp. (BRY - Free Report) and Cracker Barrel Old Country Store (CBRL - Free Report) .
5 Broker-Appreciated Stocks to Keep an Eye on After Recent Analyst Upgrades
After performing impressively in September, volatility returned to grip the U.S. equity markets in October. The hotter-than-expected inflation reading for September has reignited recession fears. In September, the consumer price index rose 0.2% month over month, beating the consensus estimate of a 0.1% rise. These matters have not improved as geopolitical woes in the Middle East have intensified.
Given these headwinds, investors are well-advised to get help from brokers, who are experts in the field of investing, to design a winning portfolio of stocks. Broker-favorite stocks such as American Airlines, Air Canada, EmergentBioSolutions, Berry Corp. and Cracker Barrel Old Country Store should be monitored for this purpose.
We have designed a screen to shortlist stocks based on improving broker recommendations and upward revisions in earnings estimates over the past four weeks. Also, since the price/sales ratio is a strong complementary valuation metric in the presence of broker information, it has been included. The price/sales ratio takes care of the company’s top line, making the strategy a well-rounded one.
Here are five of the 10 stocks that made it through the screen:
American Airlines is based in Fort Worth, TX. The gradual increase in air travel demand (particularly leisure) aids AAL. However, high operating costs are hurting its bottom line.
Over the past 60 days, the Zacks Consensus Estimate for 2024 earnings has increased 25.8%. AAL currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here
Air Canada, Canada’s leading airline, is benefitting from the buoyant scenario concerning air travel demand. Driven by this tailwind, shares of this carrier have gained 16% in the past three months.
Over the past seven days, the Zacks Consensus Estimate for 2024 earnings has inched up 0.6%. ACDVF currently carries a Zacks Rank #3 (Hold).
Emergent BioSolutions, headquartered in Gaithersburg, MD, is a life sciences company. EBS currently has a Zacks Rank #2.
Emergent BioSolutions’ shares have lost 35.2% over the past three months, underperforming the industry’s 3% decline. Bottom-line estimates for EBS have narrowed to a loss of $1.30 per share from a loss of $1.98 for 2024 in the past 30 days. The company has a favorable VGM Score of B.
Berry is primarily involved in exploration and production activities, with its operations spreading across low-decline, long-lived oil and gas reserves in California and Utah. BRY can comfortably sail through a volatile energy business environment, banking on its strong liquidity and fortress balance sheet.
BRY shares have gained 6.2% over the past month. Over the past 60 days, the Zacks Consensus Estimate for current-year earnings has increased 4.9%. BRY currently carries a Zacks Rank #3.
Cracker Barrel is prioritizing menu innovation and strategic pricing to drive growth. The company is introducing the latest offerings, including shareable starters and specialty beverages, while optimizing pricing to enhance value. These initiatives aim to attract customers and support profitability.
CBRL has outpaced the Zacks Consensus Estimate for earnings in two of the last four quarters, missing the mark on two other occasions. The average beat is 3.1%. CBRL shares have gained 10.8% over the past three months. CBRL currently carries a Zacks Rank #3.
You can get the rest of the stocks on this list by signing up now for a 2-week free trial to the Research Wizard stock picking and backtesting software. You can also create your own strategies and test them first before making investments.
The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.
Click here to sign up for a free trial to the Research Wizard today.
For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/2357887/5-broker-liked-stocks-to-keep-an-eye-on-after-recent-analyst-upgrades
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Contact: Jim Giaquinto
Company: Zacks.com
Phone: 312-265-9268
Email: pr@zacks.com
Visit: https://www.zacks.com/
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.